--:--:--

AstraZeneca Pharma India Limited

Web: astrazenecaindia.com NSE: ASTRAZEN BSE: 506820 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

6064 24(0%)

Near 52W Low of 5640

Volume

10k as on 16, Oct

Open

8,950

High

9,060

Low

8,936

Close

6,040

VWAP

5,941

52 Week High

9,850

52 Week Low

5,640

Viand Research Rating
Quality Score

18/100

Growth Score

90/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

15,160

No. of Shares

2.5

P/E

198.67

P/B

23.96

Face Value

2

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

12.06

ROCE

-

Profit Growth

-

Listing Date

04-May-01

Rank/Sector Rank

#459/#45

Promoter Holding

75%

FII Holding

2.68%

DII Holding

6.08%

Price Chart
Price Performance
1 Week2%
1 Month11%
3 Months26%
6 Months30%
1 Year36%
YTD32%
Moving Average
5 Day SMA5,931
10 Day SMA5,902
20 Day SMA6,184
30 Day SMA6,396
50 Day SMA6,837
61 Day SMA7,065
80 Day SMA7,333
200 Day SMA8,038
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 36,1385,9746,0726,186
Resistance 26,0725,9616,0216,096
Resistance 16,0045,9495,9906,052
Pivot Point5,9385,9375,9385,962
Support 15,8715,9255,8885,919
Support 25,8055,9135,8565,829
Support 35,7385,9005,8055,785
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,18,69817450%5%4%4%3755.50.0711509
2DIVISLAB2,43,96691902%0%45%38%6955.502568
3TORNTPHARM1,73,20845542%5%10%28%7255.51.792138
4ZYDUSLIFE1,11,45111170%1%20%12%2055.50.313560
5APOLLOHOSP1,09,27676002%9%4%1%5855.50.92003
6LAURUSLABS1,08,73820121%8%83%124%055.50.48890
7CIPLA1,06,15413142%2%8%19%2255.50.023862
8DRREDDY1,03,87312443%8%1%4%2055.50.24158
9MANKIND94,40122864%1%8%7%4955.50.391938
10AUROPHARMA90,84115792%1%20%52%055.50.192415
Load More
Shareholding Pattern (%)
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%
FIIs(-0.11) 2.68%(0.11) 2.78%(0.01) 2.71%(-0.31) 2.74%(0.11) 3.03%(0.01) 2.89%(0.01) 2.92%(0.11) 2.90%(0.11) 2.79%(0.11) 2.73%(0.01) 2.66%(0.01) 2.69%(0.01) 2.68%(0.11) 2.70%(0.11) 2.61%(0.01) 2.49%(0.11) 2.48%(0.01) 2.38%(0.01) 2.38%(0.01) 2.40%
DIIs(0.31) 6.08%(0.21) 5.79%(0.31) 5.55%(0.71) 5.26%(-0.11) 4.55%(-0.61) 4.65%(0.11) 5.21%(0.11) 5.08%(1.21) 4.99%(1.01) 3.77%(0.31) 2.76%(0.51) 2.42%(0.51) 1.91%(0.01) 1.41%(0.11) 1.42%(0.01) 1.32%(0.11) 1.30%(0.11) 1.19%(0.11) 1.14%(0.01) 1.05%
Public16.24%16.42%16.73%17.00%17.41%17.45%16.85%17.02%17.21%18.50%19.57%19.89%20.40%20.88%20.97%21.19%21.22%21.43%21.48%21.55%
No. of Shareholders29,33829,00731,55132,91434,37832,46627,32227,61527,16929,41829,03232,38038,94642,14645,61949,08553,98057,76062,18366,444
Quarterly Results
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Sales683579612559526480440408388383306311295285250236232232201198
Sales Growth % (YoY)29.7%20.4%38.9%37%35.8%25.4%44%31.2%31.2%34.6%22.4%31.7%27.2%22.7%24.6%19.4%32.5%10.3%0.1%-5.6%
Sales Growth % (QoQ)18%-5.4%9.5%6.3%9.6%9.1%7.8%5.2%1.3%25.2%-1.6%5.4%3.5%14%5.9%1.7%-15.4%1.5%-
Expenses634518567484445394363355349334291258228225213195204194186180
Operating Profit4961457581867753384915536760374128381518
OPM %7117131518171310134.91723211517121679
Other Income95711110-268-49910258-32774453
Interest22111100001000000000
Depreciation5643171899444444435444
Profit before tax5158477375784251-155420737123394427371616
Tax %2523302625262725-222723292526262626243026
Net Profit 3845335456583138-123916525417293320281112
Net Profit Growth % (QoQ)-15.6%36.4%-38.9%-3.6%-3.4%87.1%-18.4%416.7%-130.8%143.8%-69.2%-3.7%217.6%-41.4%-12.1%65%-28.6%154.5%-8.3%-
Net Profit Growth % (YoY)-32.1%-22.4%6.5%42.1%566.7%48.7%93.8%-26.9%-122.2%129.4%-44.8%57.6%170%-39.3%163.6%175%----
TTM Net Profit17018820119918311596819516113915213399110927151230
EPS in Rs15.1717.9513.0421.6922.3323.312.3415.37-4.7215.796.3220.9521.546.9111.7213.028.0611.194.574.78
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Sales2276171612961003806814832728571544564517474390
Sales Growth %32.6%32.5%29.2%24.5%-1%-2.2%14.2%27.6%5%-3.6%9%9.1%21.4%-26.5%
Expenses201414621111838719678711657525506547528487459
Operating Profit2622541841658613512171463716-11-13-68
OPM %1215141611171510872.9-2.2-3-18
Other Income23-5651-14151313161214762310
Interest41111110000000
Depreciation2940151617201915151617151012
Profit before tax252156220134831271147344366-210-70
Tax %2626262626273725414490027
Net Profit 188116162996293725426205-21-1-90
Net Profit Growth %62.1%-28.4%63.6%59.7%-33.3%29.2%33.3%107.7%30%300%123.8%-2000%98.9%-
EPS in Rs75.0146.364.639.7224.6437.3228.8821.7810.368.022.1-8.34-0.2-35.81
Dividend Payout %4869374041530000000
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Cash from Operating Activity-15652858101105875593857-46-1-6
Cash from Investing Activity193122185173-1714-90-4-19-15-16
Cash from Financing Activity-92-66-44-24-9-9-6000-1086-10
Net Cash Flow-883155296269-9059-13853-6471-32
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Equity Capital5555555555555555
Reserves86879476567470758450645135929624221815114616795
Borrowings11135361757912120000000
Other Liabilities1006781712545362389337306330261214193247261244206
Total Liabilities19891615151812411078985857775706562461415403412416306
Fixed Assets1174064696769748172757587971019425
CWIP0000012424745612974
Investments0000000000000000
Other Assets18721575145411721011915780690611480382324299298312208
Total Assets19891615151812411078985857775706562461415403412416306
Delivery

Delivery Data: ASTRAZEN

#Date
5640
42%
7999
Value (Cr)Q/T
9		Del
65		Del
19
121-Oct6080
5
3502
219-Oct6040
8
6575
316-Oct5970
6
4614
415-Oct5937
7
5594
514-Oct5950
7
6715
613-Oct5878
25
118421
712-Oct5919
2
4632
89-Oct5837
5
3472
98-Oct5720
4
3522
107-Oct5918
4
3442
116-Oct5980
3
3472
125-Oct5909
4
2422
131-Oct6031
7
3463
1430-Sep6186
35
89132
1529-Sep6254
5
2493
1628-Sep6280
6
3503
1725-Sep6505
4
3532
1824-Sep6591
3
3441
1923-Sep6706
3
3541
2022-Sep6712
3
3421
2121-Sep6650
3
3572
2218-Sep6752
3
4612
2317-Sep6669
1
3421
2416-Sep6703
11
4526
2515-Sep6696
10
5737
2611-Sep6764
2
3611
2710-Sep6860
2
2421
289-Sep6876
4
3392
298-Sep6876
2
3571
307-Sep6851
4
3391
314-Sep6944
5
2472
323-Sep6940
3
3521
332-Sep6868
3
2522
341-Sep6917
2
3531
3531-Aug6952
9
5767
3628-Aug7106
2
3531
3727-Aug7136
5
3542
3826-Aug7153
2
3521
3925-Aug7146
11
5677
4024-Aug7232
38
77027
4121-Aug7416
14
4588
4220-Aug7507
7
2524
4319-Aug7500
40
169137
4418-Aug7645
6
3402
4517-Aug7640
14
77210
4614-Aug7753
4
3482
4713-Aug7792
4
4643
4812-Aug7906
4
4592
Daily Market Cap
DateTotal Market CapChangeChg %
21-Oct15,160c25c0.16
19-Oct15,185c355c2.39
17-Oct14,830c00
16-Oct14,830c115c0.77
15-Oct14,945c244c1.66
14-Oct14,701c61c0.41
13-Oct14,763c49c0.33
12-Oct14,811c186c1.27
09-Oct14,625c338c2.36
08-Oct14,288c785c5.21
05-Oct15,073c168c1.10
01-Oct15,240c411c2.63
29-Sep15,651c36c0.23
28-Sep15,688c794c4.82
25-Sep16,481c188c1.12
24-Sep16,669c85c0.51
22-Sep16,754c00
17-Sep16,754c391c2.28
10-Sep17,145c214c1.23
07-Sep17,359c81c0.47
04-Sep17,440c00
Stock Checklist
Price is above from 52 week high low average: 10%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: NO
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: NO
Promoters are buying the stock: NO
Mutual Fund Holdings

Held by 55 fund scheme(s) across 7 fund house(s) as of Oct26 · Total value ₹2,291 Cr · 6 increasing / 42 decreasing · View in MF Pro →

Fund HouseSchemesWeight %ChangeValue (Cr)
Nippon India Mutual Fund40.50%-0.05%896.3
ICICI Prudential Mutual Fund240.55%-0.02%739.2
Bandhan Mutual Fund140.39%-0.24%498.3
Baroda BNP Paribas Mutual Fund81.58%-0.27%107.2
UTI Mutual Fund20.50%-0.03%26.2
ICICI Prudential Asset Management Company Limited10.24%-23.6
Motilal Oswal Mutual Fund20.02%-0
Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
For research & education only — not investment advice. Not a SEBI-registered Investment Adviser or Research Analyst. Data may be delayed or inaccurate. Investments in securities markets are subject to market risks.
0